PlainRecalls
FDA Devices Moderate Class II Ongoing

cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine

Reported: November 27, 2024 Initiated: October 17, 2024 #Z-0489-2025

Product Description

cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine

Reason for Recall

Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)

Details

Units Affected
458 units
Distribution
US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
cobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, in vitro test for total L-homocysteine. Recalled by Roche Diagnostics Operations, Inc.. Units affected: 458 units.
Why was this product recalled?
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Which agency issued this recall?
This recall was issued by the FDA Devices on November 27, 2024. Severity: Moderate. Recall number: Z-0489-2025.